CCL2 and rheumatoid arthritis: In several pathological model, such as in rheumatoid arthritis, HDAC3 inhibition determined STAT1 inactivation, resulting in reduced levels of some key pro-inflammatory cytokines such as IL-6, IL-8 and CCL-2 (87).